9-O-Demethylmitragynine (9-ODM): interactions
This page covers what 9-ODM (9-O-demethylmitragynine) may do when taken with other substances. It is not medical advice. Anyone who takes a prescribed medicine and is thinking about any kratom product should ask the prescriber or a pharmacist.
What has been studied
Nothing in people. No study has given 9-ODM to humans at all, alone or with anything else.[1] So no interaction on this page has been observed with 9-ODM itself. What is known is that it binds the mu-opioid receptor, the receptor morphine acts on: “Receptor binding assays revealed that 9-hydroxycorynantheidine has high affinity for mu-opioid receptors”.[2] That puts it in the opioid class for this purpose, and the warnings below are the opioid class warnings, applied by inference. They are not 9-ODM findings, and nothing here says a combination is safe.
Other depressants: the main risk (class inference)
The World Health Organization lists, among the things that raise the risk of an opioid overdose, “using opioids in combination with alcohol and/or other substances or medicines that suppress respiratory function, such as benzodiazepines, barbiturates, anesthetics or some pain medications”.[3] The American College of Medical Toxicology applies the same reasoning to 7-OH, the better-known mitragynine derivative: “To the extent that 7-OH is an opioid, the combination of the alkaloid with other sedatives such as alcohol, benzodiazepines, or other opioids would be expected to increase respiratory depression and overdose risk”.[4] There is less evidence for 9-ODM than for 7-OH, and the same caution applies.
- Alcohol. Named by both of the sources above.[3][4]
- Benzodiazepines (alprazolam, diazepam, clonazepam and others). The boxed warning on the alprazolam label reads: “Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death.”[5]
- Gabapentinoids (gabapentin and pregabalin). The pregabalin label says: “There is evidence from case reports, human studies, and animal studies associating LYRICA with serious, life-threatening, or fatal respiratory depression when co-administered with central nervous system (CNS) depressants, including opioids”.[6] The gabapentin label gives the same evidence “associating gabapentin with serious, life-threatening, or fatal respiratory depression when coadministered with CNS depressants, including opioids”.[7]
- Other opioids, which here include 7-OH products, MGM-15 and other relatives, and kratom leaf or extract, whose main alkaloid mitragynine is what the body turns into 9-ODM.[4][8] Stacking several products from the same shelf adds opioid effect from each.[4]
A tablet sold as 9-ODM, MIT-9 or C9 may not contain what its name suggests; this entry's general section explains why. That makes any combination harder to judge, not easier.
Liver enzymes
How the body clears 9-ODM taken on its own has not been studied.[1] One laboratory study looked at the step in which the liver makes 9-ODM from mitragynine. It found: “Ketoconazole, a CYP3A index inhibitor, demonstrated a significant effect on 9-O-demethylmitragynine formation, further implicating CYP3A4 as a major metabolic pathway”.[8] That finding is about kratom users making 9-ODM from mitragynine, not about people taking 9-ODM tablets, and the authors say “further in vitro, in vivo, and clinical studies are necessary to fully exclude any risk”.[8] Whether drugs that block or speed up liver enzymes change the amount of 9-ODM in the blood after a 9-ODM tablet is unknown.
Naloxone
In guinea-pig gut tissue, “its effect was antagonized by naloxone”, the overdose-reversal drug; that is one tissue test, not evidence about overdoses in people.[2] For 7-OH, the toxicologists advise people who use it to “obtain naloxone and learn how to administer it in case of overdose”.[4] Slow or stopped breathing after any combination is an emergency: call emergency services.
References
- PubMed search for 9-hydroxycorynantheidine OR 9-O-desmethylmitragynine OR 9-O-demethylmitragynine (run 2026-11-21: eight records; none gives the compound to people) — PubMed (US National Library of Medicine)
- Partial agonistic effect of 9-hydroxycorynantheidine on mu-opioid receptor in the guinea-pig ileum (Matsumoto et al., Life Sciences 2006) — PubMed (US National Library of Medicine)
- Opioid overdose (fact sheet) — World Health Organization
- ACMT Position Statement: Public Health Concerns Associated with 7-Hydroxymitragynine and Other Kratom Compounds (approved August 2026) — American College of Medical Toxicology
- Xanax (alprazolam) prescribing information, boxed warning (FDA label via openFDA) — US Food and Drug Administration, openFDA drug label API
- Lyrica (pregabalin) prescribing information (FDA label via openFDA) — US Food and Drug Administration, openFDA drug label API
- Neurontin (gabapentin) prescribing information (FDA label via openFDA) — US Food and Drug Administration, openFDA drug label API
- An in vitro evaluation on metabolism of mitragynine to 9-O-demethylmitragynine (Melchert, Zhang and Markowitz, Chemico-Biological Interactions 2024) — PubMed (US National Library of Medicine)
Comments
Sign in to join the conversation.
No comments yet.